EARly Prevention of aTHeroma Progression

Trial Profile

EARly Prevention of aTHeroma Progression

Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2018

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Coronary arteriosclerosis
  • Focus Therapeutic Use
  • Acronyms EARTH
  • Most Recent Events

    • 27 Jun 2018 Status changed from active, no longer recruiting to discontinued.
    • 04 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
    • 04 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top